Trending Now
LATEST ARTICLES
The Company Filed Chapter 11. The Drug Still Has Patients.
A pharmaceutical company can enter bankruptcy without its patients entering a treatment pause. Yet headlines rarely make that distinction clear. Karyopharm Therapeutics' Chapter 11...
FDA Says Some Ad Violations Could Have Been Prevented Before Launch. Why Weren’t They?
Thirty FDA enforcement letters in one year raise an uncomfortable question for drug marketers: how many campaigns could have been fixed before the first...
PhRMA Spent Nearly $59 Million on Search Ads. What Exactly Was It Selling?
What does a search ad sell when no medicine is for sale? Pharma public affairs advertising often promotes a policy position rather than a...
Lilly Is Paying to Grow the Eczema Market. Sanofi Thinks Dupixent Will Reap the...
What happens when a challenger pays to educate patients but its biggest rival captures the sale? This highlights an interesting side of competitive DTC...
Mr. Mucus Has Outlived Countless Campaigns. Pharma Should Pay Attention.
What makes a healthcare brand memorable when its advertising keeps changing? Mucinex offers a useful answer. Its longtime mascot, Mr. Mucus, continues to appear...
Roche Built the Brand. DKSH Bought It. Who Owns the Next Chapter of Rocephin?
Roche spent decades building Rocephin into a recognizable antibiotic brand. Now, DKSH has acquired commercial rights across more than 80 markets. The change in...
What If the Biggest Product Benefit Is What the Patient Gets to Avoid?
Pharmaceutical marketing usually focuses on what a treatment delivers. But what if its greatest value comes from what patients never have to experience? That...
Your Drug Has an App. FDA Says That App May Be Part of the...
Pharmaceutical companies have spent years building mobile apps to support patients between doctor visits. However, the FDA's latest guidance suggests those digital tools deserve...
PanOxyl Is 50 Years Old. Why Doesn’t Its Marketing Look Like It?
What does a 50-year-old acne brand have to do to connect with Gen Z? Apparently, it needs to stop acting its age. PanOxyl's Here...
Sensodyne Didn’t Explain Tooth Sensitivity. It Made People Feel It.
Healthcare brands are finding new ways to make their messages more personal, and sometimes that means letting consumers experience a problem firsthand. Haleon took...
